FDA issued a Warning Letter to Sunder Biomedical Tech Co. on 4/23/2004 for a previous inspection.
483 Sunder Biomedical Tech Sep 2017

483 Sunder Biomedical Tech Sep 2017

Catherine Laufmann FDA$119.00 - Available Now

FDA investigators audited the Sunder Biomedical Tech - Yunlin, Taiwan facility and issued inspectional observations (via FDA 483) on 13 Sep 2017.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 13 Sep 2017
  • Location: Yunlin, Taiwan
  • FEI: 3003656001
Add To Cart